Balancing the Risks and Benefits of Benzodiazepines
نویسندگان
چکیده
Following a September 2020 FDA announcement of boxed warning for benzodiazepines, this Viewpoint reviews the relative benefits and risks drugs to reduce overuse in at-risk patients, moderate underuse clinically appropriate instances, guide judicious, rational prescribing.
منابع مشابه
Benzodiazepines: risks and benefits. A reconsideration.
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have p...
متن کاملBalancing risks and benefits of oral contraception.
We publish in this issue an authoritative and timely opinion on the effects of third-generation oral contraceptives on the incidence of venous thromboembolism (VTE) and acute myocardial infarction (AMI) among users (Spitzer, 1997). The author is a highly experienced and leading epidemiologist in the field, and his conclusions are disturbing. He details what seems to be serious misinterpretation...
متن کاملBalancing the gastrointestinal benefits and risks of nonselective NSAIDs
Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used classes of medications to treat pain and inflammation. However, gastrointestinal complications associated with NSAIDs are prevalent, largely due to the frequent use of these agents. Adverse events associated with NSAIDs include minor side effects, such as dyspepsia, as well as serious complications, such a...
متن کاملBalancing the risks and benefits of dual platelet inhibition.
Cardiovascular and cerebrovascular events commonly arise from atherosclerotic plaque rupture that produces platelet activation, thrombus formation, and reduction of blood flow to the brain or heart. The inhibition of platelets with aspirin is effective in the secondary prevention of acute coronary events.1 The addition of clopidogrel (i.e., dual antiplatelet therapy), a platelet P2Y12receptor a...
متن کاملThe commercialization of university-based research: Balancing risks and benefits
BACKGROUND The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2021
ISSN: ['0098-7484', '1538-3598']
DOI: https://doi.org/10.1001/jama.2020.22106